美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA212367"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
45802-889-18 45802-889 HUMAN PRESCRIPTION DRUG calcipotriene and betamethasone dipropionate calcipotriene and betamethasone dipropionate SUSPENSION TOPICAL 20201009 20250731 ANDA ANDA212367 Padagis Israel Pharmaceuticals Ltd BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE MONOHYDRATE .5 mg/g; 50 ug/g 2 BOTTLE in 1 CARTON (45802-889-18) / 60 g in 1 BOTTLE
45802-889-96 45802-889 HUMAN PRESCRIPTION DRUG calcipotriene and betamethasone dipropionate calcipotriene and betamethasone dipropionate SUSPENSION TOPICAL 20201009 20250731 ANDA ANDA212367 Padagis Israel Pharmaceuticals Ltd BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE MONOHYDRATE .5 mg/g; 50 ug/g 1 BOTTLE in 1 CARTON (45802-889-96) / 60 g in 1 BOTTLE
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase